Novartis CEO Says New Purchases Will Boost Sales

April 22 (Bloomberg) -- Novartis AG Chief Executive Officer Joe Jimenez talks about the agreement to buy GlaxoSmithKline Plc’s cancer-drug business for as much as $16 billion, forming a consumer-health venture with Glaxo and selling its animal-health operation to Eli Lilly & Co. for $5.4 billion. He speaks from Basel, Switzerland, with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)
Open Access to Internet Is `Incredibly Crucial': Fry
21:29 - Feb. 27 -- Bigcommerce's Chris Fry discusses the FCC's net neutrality rules with Bloomberg's Rishaad Salamat on "Trending Business."
  • AirAsia CEO Fernandes Says Low Oil Providing Tailwind
  • Greece Needs to Raise Taxes Fast: Freris
  • Europeans Cautiously Optimistic About Greece: Harjes